Associations between myeloperoxidase and paraoxonase-1 and type 2 diabetes in patients with ischemic heart disease

被引：0
|
作者：
Katarzyna Nessler
Rafal Grzybczak
Michal Nessler
Jarosław Zalewski
Grzegorz Gajos
Adam Windak
机构：
[1] Jagiellonian University Medical College in Krakow,Department of Family Medicine, Chair of Internal Medicine and Gerontology
[2] Jagiellonian University Medical College,Department of Cardiac Rehabilitation, Institute of Cardiology
[3] Rydygier Memorial Hospital,Burns and Plastic Surgery Centre of Malopolska
[4] Jagiellonian University Medical College,Department of Coronary Disease and Heart Failure, Institute of Cardiology
[5] John Paul II Hospital,undefined
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Dysfunctional high-density lipoprotein; Myeloperoxidase (MPO); Paraoxonase-1 (PON-1); Type 2 diabetes; Ischemic heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] G192R variant of paraoxonase 1 gene is associated with ischemic heart disease in Japanese patients with type 2 diabetes mellitus.
    Odawara, M
    Tachi, Y
    Maki, H
    Yamashita, K
    Yamada, N
    DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 321 - 323
  • [22] Relationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus
    Yagci, Yagmur Ucar
    Bulbul, Buket Yilmaz
    Sut, Necdet
    Ozgun, Eray
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024,
  • [23] The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome
    Akcay, Adnan Burak
    Camsari, Ahmet
    Ozcan, Turkay
    Cicek, Dilek
    Akkus, Necdet
    Seyis, Sabri
    Cimen, Burak
    Celebi, Baris
    Doven, Oben
    Cin, Gokhan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2011, 39 (05): : 371 - 377
  • [24] Investigation of serum ischemic-modified albumin, galectin-3, paraoxonase-1, and myeloperoxidase activity levels in patients with acute brucellosis
    Dundar, Ahmet
    REDOX REPORT, 2023, 28 (01)
  • [25] Increased myeloperoxidase activity is a risk factor for ischemic heart disease in patients with diabetes mellitus
    Gorudko I.V.
    Kostevich V.A.
    Sokolov A.V.
    Bukod I.V.
    Konstantinova E.E.
    Tsapaeva N.L.
    Mironova E.V.
    Zakharova E.T.
    Vasilyev V.B.
    Cherenkevich S.N.
    Panasenko O.M.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, 5 (3) : 307 - 312
  • [26] Predisposing roles of paraoxonase-1 genetic variants in Korean ischemic stroke patients
    Cho, Yunkyung
    Kim, Jung Oh
    Jeon, Young Joo
    Choi, Gun Ho
    Shin, Jee Soo
    Cho, Sung Hwan
    Oh, Seung Hun
    Han, In Bo
    Shin, Byoung Soo
    Kim, Ok Joon
    Kim, Nam Keun
    GENES & GENOMICS, 2015, 37 (07) : 579 - 586
  • [27] Paraoxonase-1 polymorphisms and cerebral ischemic stroke: pilot study in mexican patients
    Fernanda Martinez-Salazar, Maria
    de la Luz Soriano-Martinez, Maria
    Juantorena-Ugas, Alina
    Almenares-Lopez, Damianys
    Yescas, Petra
    Boll, Marie-Catherine
    Monroy-Noyola, Antonio
    COLOMBIA MEDICA, 2018, 49 (03): : 223 - 227
  • [28] Predisposing roles of paraoxonase-1 genetic variants in Korean ischemic stroke patients
    Yunkyung Cho
    Jung Oh Kim
    Young Joo Jeon
    Gun Ho Choi
    Jee Soo Shin
    Sung Hwan Cho
    Seung Hun Oh
    In Bo Han
    Byoung Soo Shin
    Ok Joon Kim
    Nam Keun Kim
    Genes & Genomics, 2015, 37 : 579 - 586
  • [29] Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia
    Szentpeteri, Anita
    Zsiros, Noemi
    Varga, Viktoria E.
    Lorincz, Hajnalka
    Katko, Monika
    Seres, Ildiko
    Fulop, Peter
    Paragh, Gyorgy
    Harangi, Mariann
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2017, 46 (05) : 370 - 376
  • [30] Ischemic heart disease and associated risk factors in patients with type 2 diabetes
    Lazzari, R
    Zoppi, A
    Fogari, R
    JOURNAL OF HYPERTENSION, 2005, 23 : S184 - S184
12345